Pharmacokinetics and tissue distribution of liposomal etoposide in rats

References

• Abra, R.M., Hunt, C.A. (1981). Liposome disposition in vivo. III. Dose and vesicle-size effects. Biochim Biophys Acta. 666, 493–503.
   PubMed Web of Science ®Google Scholar
• Abra, R.M., Hunt, C.A., Lau, D.T. (1984). Liposome disposition in vivo. VI: delivery to the lung. J Pharml Sci. 73, 203–2066.
   PubMed Web of Science ®Google Scholar
• Allen, T.M., Cleland, L.G. (1980). Serum-induced leakage of liposome contents. Biochim Biophys Acta. 597, 418–26.
   PubMed Web of Science ®Google Scholar
• Benet, L.Z., Kroetz, D.L., Sheiner, L.B. (1996). Pharmacokinetics: the dynamics of drug absorption, distribution, and elimination. In: Goodman and Gilman’s The pharmacological basis of therapeutics. eds. Hardman, J.G., Limbird, L.E., Gilman, A.G. 9th Ed. New York: McGraw Hill, 3–27.
   Google Scholar
• Brandl, M. (2001). Liposomes as drug carriers: a technological approach. Biotechnol Annu Rev. 7, 59–85.
   PubMedGoogle Scholar
• Burgio D.E., Gosland, M.P., McNamara, P.J. (1996). Modulation effects of cyclosporine on etoposide pharmacokinetics and CNS distribution in the rat utilizing microdialysis. Biochem Pharmacol. 51, 987–92.
   PubMed Web of Science ®Google Scholar
• Figueroa, M., Gehlsen, J., Hammond, D., Ondreyco, S., Piro, L., Palmary, T., Williams, F., McMillan, R. (1993). Combination chemotherapy in refractory immune thrombocytopenic purpura. N Engl J Med. 328, 1226–9.
   PubMed Web of Science ®Google Scholar
• Fleming, R.A., Stewart, F.C. (1991). High performance liquid chromatographic determination of etoposide in plasma. J Liq Chromatog. 14, 1275–83.
   Web of Science ®Google Scholar
• Gabrielsson, J., Weiner, D. (1994). Pharmacokinetic and pharmacodynamic data analysis. Concepts and applications. Stockholm, Sweden: Swedish Pharmaceutical Press, 13.
   Google Scholar
• Gadner, H., Grois, N., Arico, M., Broadbent, V., Ceci, A., Jakobson, A., Komp, D., Michaelis, J.N., Nicholson, S., Potschger, U., Pritchard, J., Ladisch, S. (2001). A randomized trial for treatement of multisystem Langerhans’ cell histiocytosis. J Pediat. 138, 728–34.
   PubMed Web of Science ®Google Scholar
• Gibaldi, M., Perrier, D. (1982). Pharmacokinetics. Vol I. New York: Marcel Dekker Inc.
   Google Scholar
• Gregoriadis G. (1995). Engineering liposomes for drug delivery: progress and problems. Trends Biotechnol 13, 527–37.
   PubMed Web of Science ®Google Scholar
• Hande K.R. (1998). Etoposide: four decades of development of a topoisomerase II Inhibitor. Eur J Cancer. 34, 1514–21.
   PubMed Web of Science ®Google Scholar
• Hande, K., Bennett, R., Hamilton, R., Grote, T., Branch, R. (1988). Metabolism and excretion of etoposide in isolated, perfused rat liver models. Cancer Res. 48, 5692–5.
   PubMed Web of Science ®Google Scholar
• Hatta, Y., Takahashi, M., Enomoto, Y., Takahashi, N., Sawada, U., Horie, T. (2004). Adenosine phosphate (ATP) enhances the antitumor effect of etoposide (VP-16) in lung cancer. Oncol Rep. 12, 1139–42.
   PubMed Web of Science ®Google Scholar
• Herzog, T.J. (2004). Recurrent ovarian cancer:how important is it to treat to disease progression? Clin Cancer Res. 10, 7439–49.
   PubMed Web of Science ®Google Scholar
• Kelland, L.R. (2005). Emerging drugs for ovarian cancer. Expert Opin Emerging Drugs. 10, 413–24.
   PubMedGoogle Scholar
• Kim, C.K., Lee, M.K., Han, J.H., Lee, B.J. (1994). Pharmacokinetics and tissue distribution of methotrexate after intravenous injection of differently charged liposomes-encapsulated methotrexate to rats. Int J Pharm. 108, 21–29.
   Web of Science ®Google Scholar
• Martin F.J. (1998). Clinical pharmacology and antituor efficacy of DOXIL (pegylated liposomal doxorubicin). Medical applications of liposomes. New York: Elsevier Science BV, 635–88.
   Google Scholar
• Massing, U., Fuxius, S. (2000). Liposomal formulation of anticancer drugs: selectivity and effectiveness. Drug Resist Updates. 3, 171–7.
   PubMed Web of Science ®Google Scholar
• Mayou, S.C., Chu, A.C., Munro, D.D., Plowman, N. (1991). Langerhans’ cell histiocytosis—an excellent response to etoposide. Clin Exp Dermatol. 16: 292–4.
   PubMed Web of Science ®Google Scholar
• Palatini P. (1992). Disposition kinetics of phospholipid liposomes. Neurobiology of essential fatty acids. New York: Plenum Press, 375–91.
   Google Scholar
• Pardue R.L., White C.A. (1997). Pharmacokinetic evaluation of liposomal encapsulated ampicillin in male and female rats. Biopharm Drug Dispos. 18, 279–92.
   PubMed Web of Science ®Google Scholar
• Saita, T., Fujiwara, K., Kitagawa, T., Mori, M., Takata, K. (1990). A highly sensitive enzyme-linked immunosorbent assay for etoposide using β-D-galactosidase as a label. Cancer Chemo Pharmacol. 27, 115–20.
   PubMed Web of Science ®Google Scholar
• Sengupta S., Tyagi, P., Velapandian, T., Gupta, Y.K., Gupta, S.K. (2000). Etoposide encapsulated in positively charged liposomes: pharmacokinetic studies in mice and formulation stability studies. Pharmacol Res. 42, 459–64.
   PubMed Web of Science ®Google Scholar
• Senior, J.H. (1987). Fate and behavior of liposomes in vivo: a review of controlling factors. Crit Rev Ther Drug Carrier Syst. 3, 128–93.
   Google Scholar
• Sinkule, A. (1984). Etoposide: a semisynthetic epipodophyllotoxin. Chemistry, pharmacology, pharmacokinetics, adverse effects and use as an antineoplastic agent. Pharmacotherapy. 4, 61–73.
   PubMed Web of Science ®Google Scholar
• Viana, M.B., Oliveira, B.M., Silva, C.M., Rios-Leite, V.H. (1991). Etoposide in the treatment for six children with Langerhans’ cell histiocytosis (histiocytosis X). Med Pediat Oncol. 19, 289–94.
   PubMedGoogle Scholar
• Wood, L., Jacobs, P. (1988). Durable response to etoposide-loaded platelets in refractory immune thrombocytopenic purpura: a case report. Am J Hematol. 27, 63–4.
   PubMed Web of Science ®Google Scholar
• Wozniak, A.J., Ross, W.E. (1983). DNA damage as a basis for 4’-demethyl epipodophyllotoxin-9-(4, 6-O-ethylidene-β-D-glucopyranoside) (etoposide) cytotoxicity. Cancer Res. 43, 120–4.
   PubMed Web of Science ®Google Scholar
• Yu, L.C., Shenoy, S., Ward, K., Warrier, R.P. (1994). Successful treatment of multisytem Langerhans’ cell histiocytosis (histiocytosis X) with etoposide. Am J Pediat Hematol Oncol. 16, 275–7.
   PubMedGoogle Scholar